TGA Fines Oxymed Australia for COVID-19 Advertising Claims

By Sam | May 12, 2020

Australia’s Therapeutic Goods Administration (TGA) fined Oxymed Australia A$63,000 ($40,000) for making false claims that its hyperbaric oxygen therapy chambers can treat a variety of conditions, including COVID-19.
Source: The GMP Letter

Posted in The GMP Letter